Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study
Introduction: Previous studies show encouraging oncologic outcomes for neoadjuvant chemotherapy (NACT) in the setting of pancreatic ductal adenocarcinoma (PDAC). However, recent literature reported an increased clinical burden in patients undergoing pancreaticoduodenectomy (PD) following NACT. There...
Main Authors: | Nicolò Pecorelli, Michele Pagnanelli, Lorenzo Cinelli, Francesca Di Salvo, Stefano Partelli, Stefano Crippa, Domenico Tamburrino, Renato Castoldi, Giulio Belfiori, Michele Reni, Massimo Falconi, Gianpaolo Balzano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.01299/full |
Similar Items
-
Surgical management of pancreatic neuroendocrine neoplasms
by: Stefano Partelli, et al.
Published: (2014-01-01) -
Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs
by: Marina Paini, et al.
Published: (2014-01-01) -
Somatostatin analogs: is one better than other?
by: Rossana Berardi, et al.
Published: (2017-12-01) -
Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinoma
by: I. Pergolini, et al.
Published: (2019-10-01) -
The combination of preoperative celiac axis stenting and neoadjuvant chemotherapy in an elderly patient with pancreatic cancer: a case report
by: Susumu Doita, et al.
Published: (2024-03-01)